The patient presents with a genetic condition named Li-Fraumeni syndrome, which predisposes her to multiple neoplasms during her lifespan.
Due to the chemotherapeutic treatment of an osteosarcoma, the patient presents with cardiotoxicity secondary to doxorubicin that is refractory to conventional management.
The patient is initially stabilized with a peripheral veno-arterial extracorporeal membrane oxygenation device, with no improvement after 14 days of support.
Later she was assisted with a HeartMate 3 mechanical circulatory device as a bridge to candidacy or as a destination therapy.
She is the first paediatric patient in Spain to be assisted with long-term circulatory support using the HeartMate 3 device.
